Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study

por Guo, Jiajia, Yang, Houpu, Wang, Shu, Cao, Yingming, Liu, Miao, Xie, Fei, Liu, Peng, Zhou, Bo, Tong, Fuzhong, Cheng, Lin, Liu, Hongjun, Wang, Siyuan
Publicado 2017

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

por Yang, Houpu, Zhou, Lixin, Wang, Shu, Cao, Yingming, Tong, Fuzhong, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Guo, Jiajia, Wang, Siyuan, Peng, Yuan
Publicado 2018

Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients

por Peng, Yuan, Hu, Taobo, Cheng, Lin, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Miao, Liu, Hongjun, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan, Wang, Chaobin, Wang, Shu
Publicado 2021

Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study

por Peng, Yuan, Liu, Miao, Li, Xianan, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Hongjun, Cheng, Lin, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan, Wang, Chaobin, Chen, Yalin, Wang, Shu
Publicado 2021

Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center,...

por Yang, Houpu, Xu, Ling, Guan, Shan, Hao, Xiaopeng, Ge, Zhicheng, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Wang, Siyuan, Peng, Yuan, Wang, Chaobin, Wang, Shu
Publicado 2022